ARQT
HealthcareArcutis Biotherapeutics, Inc.
$30.20
+$1.20 (+4.14%)
Jan 5, 2026
Price History (1Y)
Analysis
Arcutis Biotherapeutics, Inc. operates in the healthcare sector within the biotechnology industry, employing 342 individuals worldwide. The company's market capitalization stands at $3.70 billion. The company's financial health is mixed. Arcutis reported a gross margin of 90.0%, but an operating margin of 8.6% and a profit margin of -13.9%. Return on equity was -28.2%, while return on assets was -5.9%. The company has $191.07 million in cash, $113.77 million in debt, and a current ratio of 3.50. Arcutis' valuation is characterized by a forward price-to-earnings ratio of 67.11 and an EV/EBITDA multiple of -104.70. Revenue growth was 121.7% year-over-year, but earnings growth is not available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE foam for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-255, a selective small molecule inhibitor of JAK1 for the treatment of alopecia areata; ARQ-252, a JAK1-selective topical cream in development for hand eczema and vitiligo; and ARQ-234, a CD200R fusion protein for the treatment of atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Visit website →Key Statistics
- Market Cap
- $3.70B
- P/E Ratio
- N/A
- 52-Week High
- $31.77
- 52-Week Low
- $11.13
- Avg Volume
- 2.33M
- Beta
- 1.72
Company Info
- Industry
- Biotechnology
- Exchange
- NMS
- Country
- United States
- Employees
- 342